Sarepta Therapeutics, Inc. (LON:0L35)
London · Delayed Price · Currency is GBP · Price in USD 17.29
-0.51 (-2.84%)
Feb 12, 2026, 5:10 PM GMT
Sarepta Therapeutics Market Cap
Sarepta Therapeutics has a market cap or net worth of 1.34 billion as of February 12, 2026. Its market cap has decreased by -85.17% in one year.
Market Cap
1.34B
Enterprise Value
1.64B
Revenue
1.80B
Ranking
n/a
PE Ratio
n/a
Stock Price
17.29
Market Cap Chart
Since June 4, 1997, Sarepta Therapeutics's market cap has increased from 43.06M to 1.34B, an increase of 3,008.29%. That is a compound annual growth rate of 12.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.38B | -17.67% |
| Dec 31, 2025 | 1.68B | -81.94% |
| Dec 31, 2024 | 9.28B | 31.00% |
| Dec 29, 2023 | 7.08B | -24.98% |
| Dec 30, 2022 | 9.44B | 63.02% |
| Dec 31, 2021 | 5.79B | -41.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Genus | 2.09B |
| HUTCHMED (China) | 1.88B |
| Oxford Nanopore Technologies | 1.40B |
| Oxford Biomedica | 998.08M |